At a glance
- Originator Vernalis Group
- Class Adamantanes; Small molecules
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 20 Jun 2002 Discontinued - Preclinical for Neurological disorders (Prevention) in United Kingdom (unspecified route)
- 08 Dec 2000 Preclinical development for Neurological disorders (Prevention) in United Kingdom (Unknown route)